SoWell Launches The First and Only Supplement System for GLP-1 Users to Thrive on the Medication

SoWell announced the launch of the only three-part supplement system designed specifically for GLP-1 users and their side effects: the SoWell GLP-1 Support System ($104.99). Dr. Alexandra Sowa, MD, board-certified obesity medicine specialist, and forthcoming author of ‘The Ozempic Revolution’ (HarperCollins, Winter 2025), developed this product from a decade of GLP-1 research and patient care to specifically meet the unique needs of individuals on a GLP-1 weight loss journey. Despite 50% of GLP-1 users experiencing side effects, individuals are left to navigate an overwhelming assortment of supplements that are not specifically formulated to their body’s new sensitivities or needs.

Currently, 1 in 8 Americans are using Ozempic or similar GLP-1 drugs, yet over 70% of users stop taking these life-changing medications within one year largely because of side effects they find too hard to navigate. This three-part supplement system is based on the latest clinical research and the founder’s decade-long experience working with GLP-1 patients. The SoWell GLP-1 Support System is formulated to target the unique side effects and requirements of GLP-1 users, providing comprehensive support to ensure a sustained and simplified journey on GLP-1 drugs. The product can be sold as a bundle of all three stick pack supplements, retailing for ($104.99) or available individually for flexibility: SoWell Electrolytes ($34.99), SoWell Protein ($44.99), and SoWell Fiber ($34.99).

The SoWell GLP-1 Support System extends far beyond an electrolyte, protein, and fiber supplement, combining 17 evidence-based ingredients that alleviate side effects like nausea, constipation, diarrhea, fatigue, headaches, muscle loss, weakened skin elasticity, and hair loss, all in easy-to-use stick packs. Each formulation in the protocol is enhanced with targeted ingredients to make the line more gut-friendly than alternatives and developed for the unique taste buds of GLP-1 users, who are more sensitive to overly sweet and artificial flavors. The entire system is low sugar, low carbohydrate, and free of artificial flavors, colorings, or sweeteners.

“As a physician specializing in internal and obesity medicine, I have spent over a decade working with GLP-1 patients and understanding their unique needs and challenges,” explains Dr. Alexandra Sowa, Founder of SoWell. “But other products on the market didn’t meet my standards and weren’t developed for GLP-1 users. There is a critical gap in the market when it comes to addressing the side effects and specific requirements of GLP-1 users on their weight loss journey. The SoWell GLP-1 Support System is designed to support and enhance the effectiveness of GLP-1 therapies while helping users achieve their health goals more comfortably and effectively.”

Dr. Sowa’s deep understanding of GLP-1 medications has enabled her patients to avoid the typical side effects of GLP-1 treatments. This insight drove the creation of the GLP-1 Support System, aiming to assist even more GLP-1 users throughout every step of their journey.

SoWell GLP-1 Support System Product Details:

Full GLP-1 Support System ($104.99): Includes the SoWell Electrolytes, SoWell Protein, and SoWell Fiber.

  • SoWell Electrolytes ($34.99): This daily electrolyte formula helps GLP-1 users maintain healthy hydration levels while simultaneously addressing nausea and fatigue with targeted ingredients like vitamin B6 and trace minerals. Since GLP-1 users can be sensitive to artificial and overly sweet flavors, this blend features a light, natural flavor with 0g sugar and 1g carb.
  • SoWell Protein ($44.99): By combining 25g whey isolate and collagen protein with digestive enzymes, this low-carb protein powder helps GLP-1 users maintain muscle mass, skin elasticity, and hair density as they lose weight without the digestive upset that other protein powders can cause.
  • SoWell Fiber ($34.99): GLP-1 medications slow the digestive process, which can lead to constipation and diarrhea. This triple-action blend of psyllium husk, guar gum, and apple pectin fiber works quickly to balance digestion while promoting long-term gut health. Enhanced with magnesium glycinate and 7.5 billion CFU probiotics, this one-of-a-kind formula gives GLP-1 users the gut support they need with 0g sugar and 1g net carb per serving.

For more information about SoWell or to order your first GLP-1 Support System, please visit here.

SourceSoWell

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.